Trial Profile
Clopidogrel or Ticagrelor in Acute Coronary Syndrome Patients Treated With Newer-Generation Drug-Eluting Stents: CHANGE DAPT
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Mar 2019
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Adverse reactions
- Acronyms CHANGE DAPT
- 02 Nov 2017 Results presented at the 29th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics
- 28 Jun 2017 New trial record